As ongoing tariff pressures and trade uncertainty continue to reshape global supply chains, Kinaxis® (TSX:KXS), the leader in real-time supply chain orchestration, today launched Kinaxis Tariff Response - a new offering that helps companies simulate tariff exposure, run strategic scenarios, and make data-informed decisions quickly. Built on the company’s AI-powered Maestro™ platform and delivered by Kinaxis supply chain experts, the service can be live in as few as 21 days, giving planners acc...

Armis, the cyber exposure management & security company, today announced that it has won five Global InfoSec Awards from Cyber Defense Magazine during this year’s RSAC™ Conference. Armis received the following accolades: Armis won “Editor’s Choice Cybersecurity Company” Armis Centrix™ named “Best Solution” for Cyber Exposure Management Curtis Simpson, Armis’ CISO and Chief Advocacy Officer, awarded “Publisher’s Choice CISO” Armis Centrix™ for Early Warning named “Trailblazing” prod...

AccorInvest is changing its name and becoming Essendi. This change completes the transformation initiated in 2020 to make Essendi the European leader in responsible hospitality. This new identity embodies the group's ambition: to actively contribute to a more sustainable and higher-performing hotel industry. Since 2020, Essendi has embarked on an ambitious transformation, aiming to consolidate its leadership in Europe, strengthen its overall performance and integrate ESG criteria at the heart ...

Textron Aviation today celebrated the five-year anniversary of the first flight of the versatile Cessna SkyCourier, the company’s clean-sheet twin-engine, high-wing utility turboprop. This is a significant milestone for this high-performing aircraft which has become a trusted asset for operators worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520930130/en/Cessna SkyCourier marks five years since first flight of clean-she...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, presented results from its DAZALS study of dazucorilant in patients with ALS at the European Network to Cure ALS (ENCALS) 2025 annual meeting. The presentation can be found here. This press release features...

Al Zorah Development Company, a partnership between the Government of Ajman and Solidere International, together with Four Seasons, have announced plans to open Four Seasons Resort Ajman at Al Zorah in 2026. The beachfront luxurious resort will undergo extensive upgrades to the existing property, including upgrades to accommodation and public facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428436866/en/From left: George...